About Ruth Roberts

Professor Ruth A Roberts, PhD, ATS, FBTS, ERT, FRSB, FRCPath. A co-founder of ApconiX, Ruth has 25 years of experience in leading roles in drug safety within large pharma. Ruth is also Chair and Director of Drug Discovery at The University of Birmingham, UK and was previously Global Head of Regulatory Safety at AstraZeneca. With over 140 publications in peer-reviewed journals, she is former president of the British Toxicology Society, former president of EUROTOX, former secretary to SOT and President of the Academy of Toxicological Sciences. Ruth was the recipient of the SOT Achievement award in 2002, the EUROTOX Bo Holmstedt Award in 2009 and the SOT Founders award in 2018 for outstanding leadership in toxicology. Ruth is an established science professional bringing rigorous expert thinking to toxicology, drug discovery and drug development.

ApconiX Welcomes Esther McVey MP

ApconiX Welcomes Esther McVey MP We were delighted to welcome Esther McVey MP for Tatton to ApconiX on Friday 12th of August. She congratulated us on our recent success with the Queen’s Award for Enterprise having been recognised for excellence in International Trade.  We shared with her our ambitions around [...]

By |2022-09-21T12:20:56+01:00August 17th, 2022|Company News|Comments Off on ApconiX Welcomes Esther McVey MP

Unravelling Some Mechanistic and Clinical Aspects of Immunological Drug-Drug Interactions

Unravelling Some Mechanistic and Clinical Aspects of Immunological Drug-Drug Interactions Dr Sean Hammond, as a member of an interdisciplinary team, has recently published the third of a series of papers seeking to unravel mechanistic and clinical aspects of the immunological drug-drug interactions that occur with immune checkpoint inhibitors. Immunotoxicology [...]

By |2022-09-21T12:23:33+01:00June 6th, 2022|Company News, Target Safety Assessments, Careers|Comments Off on Unravelling Some Mechanistic and Clinical Aspects of Immunological Drug-Drug Interactions

The Importance of “Agility” Post COVID

The Importance of "Agility" Post COVID In 2021, we shared our whole-hearted agreement with the 2020 Forbes Article describing agility as the new superpower.  Agility certainly allowed ApconiX to thrive and grow during the pandemic by focusing on the science and on people rather than on any pre-existing plans or process, allowing our [...]

By |2022-09-21T12:25:46+01:00June 1st, 2022|Company News|Comments Off on The Importance of “Agility” Post COVID

ApconiX Is Recruiting a Target Safety Biologist

ApconiX Is Recruiting a Target Safety Biologist The closing date for this job vacancy has passed.  Please visit our Come and Join Us page for current vacancies.  If you believe you have the skills and experience and would like to become part of our team please send your speculative CV to careers@apconix.com ApconiX [...]

By |2022-08-22T14:40:25+01:00May 31st, 2022|Company News, Target Safety Assessments, Careers|Comments Off on ApconiX Is Recruiting a Target Safety Biologist

It’s Christmas!

Christmas? Is it Late or Is it Early? The years pass so quickly and yes it's Christmas once again! ApconiX had to cancel their Christmas celebrations because of the surge in Covid19 infections over Christmas so we decided to postpone rather than cancel it. May 30th was unofficially renamed Christmas Day and Secret Santa [...]

By |2022-09-21T12:40:02+01:00May 31st, 2022|Events|Comments Off on It’s Christmas!

New Paper Published in Birth Defects Research

New Paper Published in Birth Defects Research Dr Jane Barber, Dr Claire Sadler and Dr Jane Stewart are among the authors of new paper published in Birth Defects Research. The Paper Malarial PI4K inhibitor induced diaphragmatic hernias in rat: Potential link with mammalian kinase inhibition Abstract Background MMV390048 is [...]

By |2022-08-22T14:46:46+01:00May 6th, 2022|Company News, Toxicology, Publications|Comments Off on New Paper Published in Birth Defects Research

Dr Kimberly Rockley’s Trip to San Diego Zoo

Dr Kimberly Rockley's Trip to San Diego Zoo After a busy time at SOT Dr Kimberly Rockley took an extra day and visited San Diego zoo. One of the biggest zoos in the world, it houses over 12,000 animals from over 650 different species! The Koala was snoozing as everyone from ApconiX wanted to [...]

By |2022-09-21T12:30:57+01:00April 14th, 2022|Events|Comments Off on Dr Kimberly Rockley’s Trip to San Diego Zoo

ApconiX Will Be Attending the British Society of Toxicology Congress 2022

ApconiX Attends British Society of Toxicology Congress 2022 Professor Ruth Roberts, Dr Laurence Bishop, Dr Kimberly Rockley, Dr Sean Hammond and Nicholas Coltman will be attending the British Society of Toxicology Congress 2022 from the 4th to 6th of April at the Hilton Newcastle in Gateshead UK. ApconiX will [...]

By |2022-09-21T12:32:48+01:00March 22nd, 2022|Company News, Toxicology, Events|Comments Off on ApconiX Will Be Attending the British Society of Toxicology Congress 2022

We’re Attending SOT 2022

ApconiX is Attending the 61st Society of Toxicology Annual Meeting and ToxExpo Professor Ruth Roberts, Dr Richard Knight, Dr Michael Morton, Dr Laurence Bishop, Dr James Sidaway, Dr Claire Sadler, Dr Kimberly Rockley, Simon Craige, and Dr Andrew Winkley will all be attending the SOT 2022 Annual Meeting and [...]

By |2022-09-21T12:33:49+01:00March 11th, 2022|Company News, Events|Comments Off on We’re Attending SOT 2022

Hopefully Attending Face-to-face Meetings in 2022

Hopefully Attending Face-to-face Meetings in 2022 Face-to-face meetings are back (hopefully!) and we can’t wait to get out there and share our science with the community. Our first meeting for 2022 is the ELRIG hot topic meeting on ion channels on March 16th with a focus on patient benefit [...]

By |2022-01-12T14:42:20+00:00January 12th, 2022|Company News|Comments Off on Hopefully Attending Face-to-face Meetings in 2022
Go to Top